Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Amerikaanse aandelen Terug naar discussie overzicht

Newcastle Investment Corp (NCT)

13 Posts
| Omlaag ↓
  1. [verwijderd] 26 oktober 2009 11:45
    Wie zit ook in dit commercieel vastgoedfonds?
    (onderdeel v Fortress Investment Group (FIG)
    en zus v Eurocastle).

    Vorige week 20% eraf.
    Wat zal het deze week doen?
  2. [verwijderd] 1 maart 2010 22:33
    quote:

    Sander40 schreef:

    Newcastle 12,5% gestegen in 2 dagen.
    Lijkt terug te gaan naar minimaal $2,50.

    Iemand dit aandeel in port.?
    Nu sinds vorige week woensdag rond de $2,40. Hier ligt weerstand lijkt zo laat de handel duidelijk zien. Steeds bij die $2,40 word weer verkocht.

    Ben benieuwd.

  3. [verwijderd] 8 april 2010 08:46
    quote:

    mvdh schreef:

    Zojuist aangekocht, voor 3,13. Blijft achter gezien de sector. Ben benieuwd of het sentiment meewerkt.

    Gr
    Vandaag maar eens kijken of de trend aanblijft, real estate doet het goed de laatste weken. Zie GRT maar eens, schieten toch aardig door.
    NCT liet de laatste 2 kwartalen weer een winst zien, het is wachten op dividend.

    Q4 2009 -> EPS $0.31
    Q3 2009 -> EPS $0.94

    Gr
  4. [verwijderd] 7 augustus 2010 09:21
    quote:

    mvdh schreef:

    De helft verkocht, voorzie nog wel een dip richting 3,50 usd.

    Gr
    Weer in voor de lt, 2.98.

    www.thestreet.com/story/10829797/1/ne...

    Ken Riis
    Thanks, Nitty. Good morning, everyone, and thank you for joining our second quarter 2010 conference call. Things are looking better for us. I'm encouraged by the recent activities in the capital markets and our ability to execute Newcastle’s business plan. Even in the face of a sluggish economic recovery, we are seeing a resurgence in commercial real estate lending and the continued tightening of credit spreads.

    At Newcastle, we have been very focused on executing our business plan to deleverage our balance sheet, stabilize operating earnings and increase the value and recovery of our current portfolio.

    The second quarter was a direct result of our focus and ability to execute this plan. First, we generated $22 million of net operating income compared to $30 million in the first quarter.

    Third, we improved our liquidity by $46 million in the quarter as we eliminated $20 million of short-term debt and increased unrestricted cash by $26 million. Today we have no short-term debt, $41 million of unrestricted cash on our balance sheet and $120 million of cash to reinvest in our CDOs.

    Looking at the second quarter investment activities, we were able to source $200 million of new investments at a 50% unleveraged return; there is more to come. Today we are well positioned to take advantage of the dislocations in the markets and we are currently seeing several attractive investment opportunities.
    Going forward, we are optimistic and confident in our ability to source new investments and build shareholder value.

  5. [verwijderd] 7 augustus 2010 16:27
    quote:

    mvdh schreef:

    [quote=mvdh]
    De helft verkocht, voorzie nog wel een dip richting 3,50 usd.

    Gr
    [/quote]

    Weer in voor de lt, 2.98.

    www.thestreet.com/story/10829797/1/ne...

    Ken Riis
    Thanks, Nitty. Good morning, everyone, and thank you for joining our second quarter 2010 conference call. Things are looking better for us. I'm encouraged by the recent activities in the capital markets and our ability to execute Newcastle’s business plan. Even in the face of a sluggish economic recovery, we are seeing a resurgence in commercial real estate lending and the continued tightening of credit spreads.

    At Newcastle, we have been very focused on executing our business plan to deleverage our balance sheet, stabilize operating earnings and increase the value and recovery of our current portfolio.

    The second quarter was a direct result of our focus and ability to execute this plan. First, we generated $22 million of net operating income compared to $30 million in the first quarter.

    Third, we improved our liquidity by $46 million in the quarter as we eliminated $20 million of short-term debt and increased unrestricted cash by $26 million. Today we have no short-term debt, $41 million of unrestricted cash on our balance sheet and $120 million of cash to reinvest in our CDOs.

    Looking at the second quarter investment activities, we were able to source $200 million of new investments at a 50% unleveraged return; there is more to come. Today we are well positioned to take advantage of the dislocations in the markets and we are currently seeing several attractive investment opportunities.
    Going forward, we are optimistic and confident in our ability to source new investments and build shareholder value.

    MvdH: wat doe je steeds? Instappen en verkopen als de trend weer daalt? En dan weer instappen?

    Mooie stijging voor NCT gisteren, zeker. Belangrijke stijging ook. Stijgende trend lijkt nu weer hervat te worden.

    Wat denk je van RAS? Ligt er slecht bij, maar het zakt anderszijds nauwelijks.
    Als ik de toelichting op de Q2-cijfers zolaatst heb begrepen ontbreekt het bij RAS aan een solide verdienmodel. Daarom herhaalde FBR Capital Markets het underperform-advies voor RAS (PT $1,50) op 30 juli.

    Toch lijkt...lijkt het erop, dat, als RAS enkele problemen kan tackelen de koers stevig kan uitbreken.

    Ik HAD NCT, HEB RAS nu.
    Uit wat meer beleggingservaring ga ik nu niet switchen naar NCT maar houd RAS vast.

    NCT loopt haar cumulatieve verlies snel in, bij RAS blijft het opeen zelfde niveau steken, maar het is kleiner dan bij NCT.
  6. [verwijderd] 6 december 2010 20:42
    Eindelijk weer eens een bericht. Zojuist de stukjes van NCT verkocht, gemiddelde verkoopprijs was zojuist 6,02 usd. Aan het einde van het jaar verkoop ik grotendeels van de port.

    Gr

    quote:

    mvdh schreef:

    [...]

    Weer in voor de lt, 2.98.

    www.thestreet.com/story/10829797/1/ne...

    Ken Riis
    Thanks, Nitty. Good morning, everyone, and thank you for joining our second quarter 2010 conference call. Things are looking better for us. I'm encouraged by the recent activities in the capital markets and our ability to execute Newcastle’s business plan. Even in the face of a sluggish economic recovery, we are seeing a resurgence in commercial real estate lending and the continued tightening of credit spreads.

    At Newcastle, we have been very focused on executing our business plan to deleverage our balance sheet, stabilize operating earnings and increase the value and recovery of our current portfolio.

    The second quarter was a direct result of our focus and ability to execute this plan. First, we generated $22 million of net operating income compared to $30 million in the first quarter.

    Third, we improved our liquidity by $46 million in the quarter as we eliminated $20 million of short-term debt and increased unrestricted cash by $26 million. Today we have no short-term debt, $41 million of unrestricted cash on our balance sheet and $120 million of cash to reinvest in our CDOs.

    Looking at the second quarter investment activities, we were able to source $200 million of new investments at a 50% unleveraged return; there is more to come. Today we are well positioned to take advantage of the dislocations in the markets and we are currently seeing several attractive investment opportunities.
    Going forward, we are optimistic and confident in our ability to source new investments and build shareholder value.

13 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.846
AB InBev 2 5.300
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.925
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 9.024
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 32
Adomos 1 126
AdUX 2 457
Adyen 13 16.585
Aedifica 2 832
Aegon 3.257 320.292
AFC Ajax 537 7.025
Affimed NV 2 5.776
ageas 5.843 109.782
Agfa-Gevaert 13 1.888
Ahold 3.536 74.015
Air France - KLM 1.024 34.380
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.778
Alfen 12 16.818
Allfunds Group 3 1.232
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 340
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.771
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.456
AMG 965 126.441
AMS 3 73
Amsterdam Commodities 303 6.527
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 383
Antonov 22.632 153.605
Aperam 91 14.182
Apollo Alternative Assets 1 17
Apple 5 322
Arcadis 251 8.628
Arcelor Mittal 2.024 318.749
Archos 1 1
Arcona Property Fund 1 267
arGEN-X 15 9.175
Aroundtown SA 1 184
Arrowhead Research 5 9.304
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.756
ASML 1.762 77.462
ASR Nederland 18 4.161
ATAI Life Sciences 1 7
Atenor Group 1 335
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.770
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 17 mei

    1. Japan economische groei Q1
    2. China detailhandelsverkopen april
    3. China industriële productie april
    4. Sif Q1-cijfers
    5. Engie Q1-cijfers
    6. Corbion ex €0,61 dividend
    7. EU inflatie april (def)
    8. VS voorlopende indicatoren april
  2. 20 mei

    1. Dui, producentenprijzen april
    2. Ryanair jaarcijfers
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht